Found: 15
Select item for more details and to access through your institution.
Clinical Interest in Exome-Based Analysis of Somatic Mutational Signatures for Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 3115, doi. 10.3390/cancers16173115
- By:
- Publication type:
- Article
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7592, doi. 10.3390/ijms24087592
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamic of Alpelisib.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 1, p. 45, doi. 10.1007/s40262-022-01195-2
- By:
- Publication type:
- Article
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01829-4
- By:
- Publication type:
- Article
Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.863057
- By:
- Publication type:
- Article
Small Cell Neuroendocrine Carcinoma of the Paranasal Sinuses with Unexpected Location and Clinical Presentation and Occupational Exposure: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 280, doi. 10.3390/cancers16020280
- By:
- Publication type:
- Article
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1299, doi. 10.3390/cancers15041299
- By:
- Publication type:
- Article
Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3020, doi. 10.3390/cancers13123020
- By:
- Publication type:
- Article
The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 201, doi. 10.3390/cancers11020201
- By:
- Publication type:
- Article
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00395-0
- By:
- Publication type:
- Article
Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 10, p. 1708, doi. 10.3390/pharmaceutics13101708
- By:
- Publication type:
- Article
Population Pharmacokinetics of Palbociclib in a Real-World Situation.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 3, p. 181, doi. 10.3390/ph14030181
- By:
- Publication type:
- Article
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 801, doi. 10.1007/s11523-021-00848-9
- By:
- Publication type:
- Article